These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12205502)

  • 1. Sunbaked biotechnology in Australia.
    Littlejohn T
    Nat Biotechnol; 2002 Sep; 20(9):873-7. PubMed ID: 12205502
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioentrepreneurship around the world.
    Persidis A
    Nat Biotechnol; 1998 May; 16 Suppl():3-4. PubMed ID: 9591247
    [No Abstract]   [Full Text] [Related]  

  • 3. Australia: ready for business.
    Woodrow GC; Nisbet I; Corbett ME
    Nat Biotechnol; 1997 Aug; 15(8):731-2. PubMed ID: 9255783
    [No Abstract]   [Full Text] [Related]  

  • 4. Europe discovers bioentrepreneurship.
    Haycock P
    Nat Biotechnol; 1998 May; 16 Suppl():6. PubMed ID: 9591249
    [No Abstract]   [Full Text] [Related]  

  • 5. Row over industry link-up splits staff of Spanish lab.
    Fernandez Hermana LA
    Nature; 1994 Dec; 372(6507):586. PubMed ID: 7990935
    [No Abstract]   [Full Text] [Related]  

  • 6. The biotechnology revolution and world health.
    Nossal SG
    Public Health Rep; 1998; 113(2):122-7. PubMed ID: 9719812
    [No Abstract]   [Full Text] [Related]  

  • 7. A brave new medicine. A conversation with William Haseltine.. Interview by Joe Flower.
    Hasetine W
    Health Forum J; 1999; 42(4):28-30, 61-5. PubMed ID: 10539016
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotechnology mergers and acquisitions.
    Champsi FH
    Nat Biotechnol; 1998 May; 16 Suppl():61-2. PubMed ID: 9591276
    [No Abstract]   [Full Text] [Related]  

  • 9. How will biotechnology fare in pharma's big plan?
    Nat Biotechnol; 1996 Nov; 14(11):1515. PubMed ID: 9634811
    [No Abstract]   [Full Text] [Related]  

  • 10. The future direction of Australian biotechnology. The report of the Biotechnology Consultative Group.
    Aust J Biotechnol; 1988 Sep; 2(2):103-5. PubMed ID: 2485321
    [No Abstract]   [Full Text] [Related]  

  • 11. How do you measure "success" in a biotechnology company?
    Greetham EM
    Nat Biotechnol; 1998 May; 16 Suppl():59-60. PubMed ID: 9591275
    [No Abstract]   [Full Text] [Related]  

  • 12. Genomic sciences and the medicine of tomorrow.
    Drews J
    Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
    [No Abstract]   [Full Text] [Related]  

  • 13. Public biotech 98: the numbers.
    Lähteenmäki R; Michael A; Marshall A
    Nat Biotechnol; 1999 May; 17(5):429-32. PubMed ID: 10331795
    [No Abstract]   [Full Text] [Related]  

  • 14. The three pillars of bioentrepreneurship.
    Schoemaker HJ; Schoemaker AF
    Nat Biotechnol; 1998 May; 16 Suppl():13-5. PubMed ID: 9591253
    [No Abstract]   [Full Text] [Related]  

  • 15. The power of genomics to transform the biotechnology industry.
    Haseltine WA
    Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259
    [No Abstract]   [Full Text] [Related]  

  • 16. The evolving role of collaboration in biotechnology.
    Gower JM
    Nat Biotechnol; 1998 May; 16 Suppl():31-2. PubMed ID: 9591261
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotechnology in Australia in 1993.
    Fayle D; Playne M
    Australas Biotechnol; 1994; 4(6):325-32. PubMed ID: 7765826
    [No Abstract]   [Full Text] [Related]  

  • 18. What the U.S. biopharmaceutical industry wants.
    Raines LJ
    Biotechnology (N Y); 1991 Mar; 9(3):244-6. PubMed ID: 1367298
    [No Abstract]   [Full Text] [Related]  

  • 19. Where have all the investors gone?: the case for consolidation.
    Esposito RS; Ostro MJ
    Nat Biotechnol; 1998 May; 16 Suppl():63. PubMed ID: 9591277
    [No Abstract]   [Full Text] [Related]  

  • 20. Bid to limit prices on drugs using 'public' discoveries.
    Wadman M
    Nature; 1998 May; 393(6683):297. PubMed ID: 9620788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.